Cited by 67Cannabis and Cannabinoid ResearchPain Mechanisms and TreatmentsIon Channels and Receptors

Inhibition of fatty acid amide hydrolase unmasks CB1receptor and TRPV1 channel‐mediated modulation of glutamatergic synaptic transmission in midbrain periaqueductal grey

Open access
Kawahara, H, Drew, GM, Christie, MJ, Vaughan, CW·2011·British Journal of Pharmacology

Abstract

BACKGROUND AND PURPOSE: While arachidonyl ethanolamine (anandamide) produces pharmacological effects mediated by cannabinoid CB1 receptors, it is also an agonist at the transient receptor potential vanilloid type 1 (TRPV1) ion channel. This study examined the cellular actions of anandamide in the midbrain periaqueductal grey (PAG), a region implicated in the analgesic actions of cannabinoids, and which expresses both CB1 receptors and TRPV1. EXPERIMENTAL APPROACH: In vitro whole cell patch clamp recordings of glutamatergic excitatory postsynaptic currents (EPSCs) were made from rat and mouse PAG slices. KEY RESULTS: Capsaicin (1 µM) increased the rate, but not the amplitude of miniature EPSCs in subpopulations of neurons throughout the rat and mouse PAG. Capsaicin had no effect on miniature EPSCs in PAG neurons from TRPV1 knock-out mice. In mouse PAG neurons, anandamide (30 µM) had no effect on the rate of miniature EPSCs alone, or in the presence of either the CB1 antagonist AM251 (3 µM) or the TRPV1 antagonist iodoresiniferatoxin (300 nM). Anandamide produced a decrease in miniature EPSC rate in the presence of the fatty acid amide hydrolase (FAAH) inhibitor URB597 (1 µM). By contrast, anandamide produced an increase in miniature EPSC rate in the presence of both URB597 and AM251, which was absent in TRPV1 knock-out mice. CONCLUSIONS AND IMPLICATIONS: These results suggest that the actions of anandamide within PAG are limited by enzymatic degradation by FAAH. FAAH blockade unmasks both presynaptic inhibition and excitation of glutamatergic synaptic transmission which are mediated via CB1 receptors and TRPV1 respectively.

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2010.01157.x

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • There is evidence of presynaptic expression of TRPV1 in the nucleus tractus solitarus and periaqueductal grey.

    “There is also evidence of presynaptic expression of TRPV1 in the nucleus tractus solitarus and PAG (Kawahara et al., 2011).”

    From The endocannabinoid system as a target for novel anxiolytic drugs (2017) · cites this paper as Kawahara et al., 2011

  • Available evidence suggests that effects at TRPV1 are in opposition to the anti-anxiety-like behavioral actions exerted through CB1R.

    “As the available evidence suggests that effects at TRPV1 appear to be in opposition to the (anti-anxiety-like) behavioral actions exerted through CB1R (Kawahara et al., 2011)”

    From The endocannabinoid system as a target for novel anxiolytic drugs (2017) · cites this paper as Kawahara et al., 2011

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kawahara, H., Drew, G., Christie, M., & Vaughan, C.
Affiliations
The University of Sydney (AU)
Corresponding author
Kawahara, H
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2011-06-27
Volume
163
Issue
6
Pages
1214-1222
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W1514108563
Cited by
67
References
56
Citations by year
2025: 3 · 2024: 3 · 2023: 1 · 2022: 2 · 2021: 6 · 2020: 6 · 2019: 3 · 2018: 6 · 2017: 3 · 2016: 4 · 2015: 3 · 2014: 10 · 2013: 6 · 2012: 7
FWCI
4.01
Type
journal article
Language
en
Open access
Locations
  • British Journal of Pharmacology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Health and Medical Research Council
  • National Medical Research Council
Topics
  • Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
  • Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
  • Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
Keywords
anandamide, fatty acid amide hydrolase, CB1 receptor, TRPV1, periaqueductal gray, glutamatergic neurotransmission, presynaptic inhibition, capsaicin, URB597, AM251, cannabinoid analgesia, excitatory postsynaptic currents
MeSH terms
Fatty Acid Amide Hydrolases, Amidohydrolases, Animals, Arachidonic Acids, Capsaicin, Female, Male, Mice, Inbred C57BL, Synaptic Transmission, Periaqueductal Gray, Rats, Sprague-Dawley, Mice, Knockout, Receptor, Cannabinoid, CB1, TRPV Cation Channels, Mice, Rats, Polyunsaturated Alkamides, Cannabinoid Receptor Modulators, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review